Format

Send to

Choose Destination
Eur J Clin Microbiol Infect Dis. 1997 Nov;16(11):846-8.

Potentiation of antifungal activity of amphotericin B by azithromycin against Aspergillus species.

Author information

1
Department of Medicine, University of Florida College of Medicine, and VA Medical Center, Gainesville 32610, USA.

Abstract

The potential role of azithromycin in combination with amphotericin B against 25 clinical isolates of Aspergillus was assessed. The MIC of amphotericin B was 1 microg/ml for 44% of the isolates, 0.5 microg/ml for 48%, and 0.25 microg/ml for 8%. All isolates were resistant to azithromycin. Synergism, defined as a > or = twofold reduction in the MIC of both drugs upon combination, was demonstrated between amphotericin B and azithromycin for all 25 isolates. To prove that azithromycin exerts its antifungal effect by inhibiting protein synthesis, we studied [35S]-methionine incorporation into protein in one Aspergillus isolate. Neither amphotericin B at 0.125 microg/ml (fourfold below its MIC) nor azithromycin at 16 microg/ml (> or = 16-fold below its MIC) had any effect on protein synthesis when tested alone. Upon combination, however, a 68% inhibition in protein synthesis was evident by the inhibition of [35S]-methionine incorporation.

PMID:
9447909
DOI:
10.1007/bf01700417
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center